Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
P3 Health Partners operates a value-based care platform managing Medicare Advantage and other at-risk patient populations across Nevada, Oregon, Arizona, and New Mexico. The company partners with health plans and providers to manage medical costs through care coordination, utilization management, and risk-sharing arrangements. Severe financial distress is evident with negative equity, critical liquidity constraints (0.32 current ratio), and 80%+ stock decline indicating potential bankruptcy or restructuring risk.
P3 receives per-member-per-month capitated payments from health plans to manage total medical costs for assigned patient populations. Profitability depends on keeping actual medical expenses below capitated revenue through care coordination, preventive care, and utilization management. The model requires accurate risk adjustment coding and effective cost containment - the company captures spread between capitation payments and medical loss ratio. Current negative margins suggest medical costs are exceeding capitated revenue, indicating underpricing of risk, adverse selection, or operational execution failures. Limited pricing power as health plans negotiate rates based on competitive bids and historical performance.
Medical loss ratio (MLR) performance versus capitated revenue assumptions - any deterioration signals underwriting losses
Medicare Advantage membership growth and retention rates in Nevada, Oregon, Arizona, New Mexico markets
Risk adjustment factor (RAF) scores and CMS payment rate changes affecting per-member revenue
Liquidity events, debt covenant compliance, and going-concern disclosures given critical balance sheet stress
Health plan contract renewals and pricing negotiations with major partners
CMS Medicare Advantage rate pressure and risk adjustment methodology changes could reduce per-member revenue without corresponding medical cost relief
Shift toward direct contracting models where health plans vertically integrate care delivery, disintermediating third-party risk-bearing entities
Regulatory scrutiny of risk adjustment coding practices and potential retrospective payment adjustments
Larger, better-capitalized value-based care platforms (Humana integrated care, UnitedHealth Optum, Elevance CareMore) have superior scale, data analytics, and provider network leverage
Health plans increasingly building internal care management capabilities rather than outsourcing risk
Regional competitors with deeper local provider relationships in Nevada, Oregon, Arizona, New Mexico markets
Imminent bankruptcy or restructuring risk given negative equity (-$2.71 debt/equity), critical liquidity (0.32 current ratio), and massive cash burn
Potential equity wipeout in debt restructuring or going-concern event - stock trading at near-zero valuation suggests market pricing this outcome
Medical claims payable volatility could trigger additional cash needs if reserves prove inadequate
low - Medicare Advantage enrollment is relatively recession-resistant as it serves seniors with government-funded coverage. However, Medicaid expansion populations (if any) could see enrollment volatility with economic cycles. Medical utilization patterns can shift during recessions (deferred elective procedures) but chronic disease management remains stable. Current financial distress is company-specific execution issue rather than macro-driven.
Rising rates significantly pressure valuation multiples for unprofitable growth companies and increase refinancing costs. With negative equity and likely covenant pressures, higher rates could accelerate liquidity crisis if debt needs restructuring. However, operating business has minimal direct rate sensitivity as Medicare reimbursement rates are government-set and not tied to market rates. Primary impact is through cost of capital and ability to access refinancing.
Critical - Company appears dependent on credit markets for survival given negative operating cash flow ($-0.1B), minimal current ratio (0.32), and negative equity. Tightening credit conditions or high-yield spread widening would severely constrain refinancing options. Likely facing covenant pressures or default risk. Health plan partners may also require increased reserves or guarantees if creditworthiness deteriorates further, creating additional liquidity drain.
distressed/special situations investors and bankruptcy traders given near-total equity value destruction. Former growth investors have clearly exited. Current holders likely include distressed debt funds positioning for restructuring, retail capitulation sellers, and potentially short sellers covering. Not suitable for traditional value, growth, or income investors given going-concern uncertainty. Extreme volatility and binary outcomes (restructuring vs. liquidation) characterize current investor base.
extreme - 61.9% decline in three months and 80.3% annual loss indicates distressed security behavior with high daily volatility. Low liquidity and near-zero market cap amplify price swings. Beta likely elevated but less meaningful than absolute volatility and event risk.
